Tianjin Chase Sun Pharmaceutical Co.,Ltd

¥3.22As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300026Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.87%)
Div yield 0.31%
ROE 0.28%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.07
PE TTM 253.8
TSR TTM (15.45%)
Mkt cap ¥9.673B
ROIC 0.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.16
29.14%
(33.03%)
Hold 5|8|2|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.05
0.05
0.05
12.18%
15.64%
25.70%
25.32%
Revenue¥M
741.1
771.4
794.2
785.5
(1.09%)
(2.81%)
1.56%
2.94%
Peers (US$1.450B)
Cap (US$)
PE
1.503B
343.0x
1.400B
126.8x
1.461B
39.91x
Capital
TTM
5Y
10Y
Leveragex
0.764
(0.054)
(0.051)
EBIT/Intx
2.944
0.231
0.226
Own earn%
83.14
39.44
76.04
Sh yield%
50.41
14.86
16.16
Owners
Insiders/Inst%
2.51
72.75
Short interest%
1.94
SBC / revenue%
5.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–20
$1 testx
0.0
Incr. ROIC%
7